my account  log out
 

Afuco™ Anti-Human CTSS ADCC Theraputic Antibody (Fsn0503h), ADCC Enhanced

Create: 08/09/2019
Expired Date:never
Category: Drugs&Pharmaceutical [Health&Medical&Pharmaceutical]
Message:Anti-CTSS ADCC Enhanced Antibody (Fsn0503h) is an ADCC enhanced antibody produced by our Afuco™ platform. Fsn0503h is a fully human anti-Cathepsin S antibody with anti-tumour and anti-angiogenic properties. Cathepsin S is a cysteine protease highly expressed in many cancers including colorectal, breast, prostate and glioblastoma's. It is involved in tumour progression through extracellular matrix remodelling. Fusion Therapeutics has generated positive preclinical data demonstrating efficacy of Fsn0503h in multiple models both as a monotherapy and in combination with approved agents. https://www.creativebiolabs.net/Anti-CTSS-ADCC-Enhanced-Antibody-Fsn0503h-20492.htm
City:Shirley[US] 
Location:
 
Feb 01 2023 VBS++ (with Ca and Mg) Buffer232
Feb 01 2023 GVBE Buffer232
Feb 01 2023 GVB++ (with Ca and Mg) Buffer239
Feb 01 2023 Hemolysin (Rabbit Anti-Sheep Cell Hemolysin)226
Aug 30 2019Anti-HSV-2 gH Antibody420
Aug 30 2019Anti-L. major LPG Antibody501
Aug 30 2019Anti-DENV-1 Antibody410
Aug 30 2019Anti-BPV-1 L1 Antibody427
Aug 30 2019Anti-H3N2 HA Antibody408
Aug 30 2019Anti-EIAV env Antibody435

return back

Copyright © toextrade Inc. All rights reserved. Contact us